Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.67
$0.393.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -96.65% | -2.91% | |||
| Gross Profit | 96.65% | 2.91% | |||
| SG&A Expenses | -10.29% | -4.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.49% | 2.64% | |||
| Operating Income | -27.49% | -2.64% | |||
| Income Before Tax | -32.16% | -4.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.16% | -4.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -32.16% | -4.03% | |||
| EBIT | -27.49% | -2.64% | |||
| EBITDA | -27.58% | -2.80% | |||
| EPS Basic | -31.44% | -3.70% | |||
| Normalized Basic EPS | -31.45% | -3.70% | |||
| EPS Diluted | -31.44% | -3.70% | |||
| Normalized Diluted EPS | -31.45% | -3.70% | |||
| Average Basic Shares Outstanding | 0.55% | 0.31% | |||
| Average Diluted Shares Outstanding | 0.55% | 0.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||